Related Experiment Video
Updated: Apr 26, 2026
07:29
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
20.2K
Metformin pharmacogenomics: current status and future directions
Aaron C Pawlyk1, Kathleen M Giacomini2, Catherine McKeon1
1Division of Diabetes, Endocrinology, and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
Diabetes
|July 26, 2014
Summary
Pharmacogenomics research aims to personalize type 2 diabetes treatment. Understanding genetic variations in metformin response can improve drug efficacy and safety for patients.
Area of Science:
- Pharmacogenomics
- Precision Medicine
- Diabetes Treatment
Background:
- Type 2 diabetes (T2D) incidence and healthcare costs are increasing.
- Metformin is a widely used first-line T2D drug, but patient response varies significantly.
- Lack of response predictors limits optimal metformin use.
Purpose of the Study:
- Review current metformin pharmacogenomics research.
- Identify challenges in understanding patient response variability.
- Explore using genetic insights for improved T2D patient outcomes.
Main Methods:
- Leveraging "omics" approaches for discovery.
- Utilizing pharmacogenomics as a key discovery tool.
- Analyzing genetic factors influencing metformin response.
Main Results:
- Pharmacogenomics offers potential for personalized T2D therapy.
- Understanding genetic determinants can guide treatment selection.
- Identifies opportunities for novel diabetes drug development.
Conclusions:
- Genetic insights into metformin response are crucial for precision medicine.
- Tailoring T2D treatments based on pharmacogenomics can enhance efficacy and safety.
- Further research can lead to better diabetes management strategies.
Related Concept Videos
01:27Pharmacogenetics of Drug Metabolism: Overview
191
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
191
01:29Pharmacogenomics: Identification of New Drug Targets
119
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
119
01:29Pharmacogenetics and Pharmacogenomics: Overview
246
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
246
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
81
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
156
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
156
01:27Principles of Pharmacogenetics: Types of Genetic Variants
135
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
135